By using mRNA molecules to “remodel” parts of the immune system, researchers generated T cells that can slow the growth of ...

Trial led Nashat Gabrail, M.D., will assess dose-finding, safety and preliminary efficacy of STAR-LLD plus elranatamab ...

Final phase 1 results showed lasting responses to soquelitinib in some patients with relapsed or refractory T cell lymphoma.

Chemotherapy remains what many people picture when they hear a cancer diagnosis, but treatment for certain blood cancers now ...

Zika virus has been spreading for decades, but it first grabbed worldwide headlines in 2016. That February, with an outbreak sweeping the Americas, the World Health Organization (WHO) declared the ...

Researchers at MIT have found a way to use a nontoxic antifreeze sugar to protect CAR-T cells from damage during storage and ...

Beyond the potential clinical application, the study sheds new light on T cell biology and how cells are directed towards specific lineages.

The immune system possesses legions of T cells that, if primed, could hunt down and destroy tumors. Now, a UC San Francisco ...

The immune system may learn not to attack the body by using a small but representative sample of the body’s own protein ...

Data supports ongoing registration Phase 3 trial in r/r PTCL, Phase 2 trial in atopic dermatitis and planned trials for hidradenitis suppurativa and asthma Data in T cell lymphoma demonstrated ...

T cells may be able to do something scientists did not previously know they could: physically sense the tissues around them. A McGill University -led study suggests this ability could reshape ...